术前影像动脉钙化与外周动脉疾病临床结局的系统综述
该系统综述检索截至2024年9月1日的PubMed、Embase和Cochrane CENTRAL,纳入51项研究共10522例有症状的外周动脉疾病患者,评估术前影像动脉钙化评分与临床结局的关联。随钙化评分升高,主要肢体不良事件、截肢、主要心血管不良事件和死亡率呈升高趋势,但样本量较小且钙化评分方法异质性大,需谨慎解读。
要点
- 钙化评分升高与主要肢体不良事件、截肢、主要心血管不良事件和死亡率升高呈趋势相关。
- 纳入研究钙化评分方法、患者人群和干预方式异质性较大,结果需谨慎解读。
- 需进一步标准化钙化评分并在更大队列中验证,以推动临床实践应用。
核心结论
- 进一步标准化钙化评分并在更大队列中开展随访研究,是确认钙化评分与主要不良事件关联及推动临床实践应用的必要条件。
研究设计与样本
- 系统综述检索PubMed、Embase和Cochrane CENTRAL至2024年9月1日,共获得2963条记录。
- 最终纳入51项研究,共10522例有症状的外周动脉疾病患者(间歇性跛行或慢性肢体威胁性缺血)。
- 纳入研究的平均随访时间为6至46个月,偏倚风险采用QUIPS方法评估。
主要发现
- 随着钙化评分升高,主要肢体不良事件、截肢、主要心血管不良事件和死亡率呈现升高的明显趋势。
- 由于样本量相对较小以及钙化评分方法、患者人群和所行干预的异质性,上述结果需谨慎解读。
关键数值与推荐
- 纳入标准包括:英文撰写、报告原始数据、招募有症状的外周动脉疾病患者、基于术前或替代无创影像对肾下主动脉和/或远端动脉进行钙化定量评分、比较不同定量或半定量钙化评估患者的临床结局。
临床怎么用
- 目前证据尚不足以支持将钙化评分常规用于临床实践,需进一步标准化评分方法和更大规模随访研究验证。
局限性
- 纳入研究样本量相对较小。
- 钙化评分方法存在异质性。
- 患者人群和所行干预存在异质性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Peripheral arterial disease may lead to chronic limb-threatening ischemia, which is associated with major amputation and mortality. Early detection of patients at risk for poor outcomes could allow for patient-tailored prevention and treatment strategies, averting these adverse events. Coronary and aortic calcification have previously been shown to predict future cardiovascular events and mortality. The objective of this review was to investigate the association between peripheral artery calcification and clinical outcomes in symptomatic patients with peripheral arterial disease, either in the natural course or after revascularization. METHODS: A systematic search in PubMed, Embase, and Cochrane CENTRAL up until September 1, 2024, yielded 2963 records. Studies were included if they: (1) were written in English; (2) reported original data; (3) recruited symptomatic patients with peripheral arterial disease (with claudication or chronic limb-threatening ischemia); (4) quantified arterial calcification in the infrarenal aorta and/or distal arteries with a calcium score based on preoperative or alternative noninvasive imaging; and (5) compared clinical outcomes between patients with a range of quantitative or semiquantitative calcification assessments. Risk of bias was assessed using the Quality In Prognosis Studies (QUIPS) method. RESULTS: A total of 51 studies (N = 10,522 patients) met the inclusion criteria. Twelve studies (n = 1058) used quantitative scores, 37 used semiquantitative scores (n = 9208), and two used both (n = 256). Mean follow-up of included studies ranged between 6 and 46 months. A clear trend towards a higher rate of major adverse limb events, amputation, major adverse cardiovascular events, and mortality was found with increasing calcium scores. However, relatively low sample sizes and heterogeneity in calcium scoring methods, patient population, and performed interventions warrant cautious interpretation of these results. CONCLUSION: Further standardization of calcium scoring and follow-up studies in larger cohorts are needed to confirm the observed associations between calcification scores and major adverse events and to facilitate implementation of calcium scoring in clinical practice.
引用
- Wiggers RBM, Harmsen IM, Kok M, et al. A systematic review of the association between arterial calcification on preoperative imaging and clinical outcomes in peripheral arterial disease. J Vasc Surg. 2025. PMID: 40581192. doi:10.1016/j.jvs.2025.06.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。